Overview
Sclerifuma 240 mg Capsules contain Dimethyl Fumarate, a disease-modifying therapy primarily prescribed for relapsing forms of multiple sclerosis (MS). It works by modulating the immune system and reducing inflammation, thereby helping to slow disease progression and reduce the frequency of relapses. The delayed-release (DR) formulation improves gastrointestinal tolerability.





